Trials / Withdrawn
WithdrawnNCT04292860
Reverse Axillary Mapping in Breast Radiation Treatment Planning
Reverse Axillary Mapping as a Lymphedema Prevention Strategy in Breast Radiation Treatment Planning
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this prospective study is to investigate the role of axillary reverse mapping (ARM) in radiation therapy planning of patients with breast cancer. Lymphedema is a common side effect after surgery and radiation therapy for breast cancer. The use of ARM is becoming more routine in surgery to differentiate the upper extremity lymphatics (UELs) from the breast axillary drainage to preferentially spare the UELs and reduce the rates of lymphedema.
Conditions
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2022-01-01
- Completion
- 2027-01-01
- First posted
- 2020-03-03
- Last updated
- 2021-05-27
Source: ClinicalTrials.gov record NCT04292860. Inclusion in this directory is not an endorsement.